A Case of Hepatocellular Carcinoma Diagnosed with Resistant Hypoglycemia
- 1 Department of Gastroenterology, Medical Faculty, Atatürk University, Erzurum, Turkey
- 2 Department of Internal Medicine, Medical Faculty, Atatürk University, Erzurum, Turkey
- 3 Department of Internal Medicine, Medical Faculty, Atatürk University, Erzurum, Turkey
Abstract
Background: There are many causes of the etiology of hypoglycemia. Hypoglycemia is very rare in individuals without diabetes. Although it can accompany islet cell malignancies such as insulinoma, it is much less common in solid organ tumors such as hepatocellular carcinoma as a component of paraneoplastic syndrome. Case Presentation: We present a 58-year-old male patient with no additional disease, who was examined for resistant hypoglycemia and was diagnosed as having hepatocellular carcinoma radiologically for the first time. Insulin level measured when serum glucose was 44 mg/dl: 0.4 μ U/mL, c-peptide level: 0.355 ng/mL detected. Viral serology was found to be positive for HbsAg. In dynamic magnetic resonance imaging, showing continuity in segments 6 - 7 and 8 in the right lobe, and also partially towards 5, heterogeneous hyperintense in T2 A’s, diffusion-limiting, heterogeneous contrast enhancement in postcontrast series, cystic-necrotic in the center. The alpha-fetoprotein level was 60,500 ng/mL. Conclusion: Paraneoplastic hypoglycemia due to underlying malignancies should be considered in patients presenting with hypoglycemia.
- Bergman, P.J. (2001) Paraneoplastic Syndromes. In: Withrow, S.J., MacEwen, E.G., Eds., Small Animal Clinical Oncology, 3rd Edition, Saunders, Philadelphia, 35-53.
- Luo, J.C., Hwang, S.J., Wu, J.C., Lai, C.R., Li, C.P., Chang, F.Y., et al. (2002) Clinical Characteristics and Prognosis of Hepatocellular Patients with Paraneoplastic Syndromes. Hepatogastroenterology, 49, 1315-1319.
- Saigal, S., Nandeesh, H.P., Malhotra, V. and Sarin, S.K. (1998) A Case of Hepatocellular Carcinoma Associated with Trouble Some Hypoglycemia: Management by Cytoreduction Using Percutaneous Ethanol Injection. American Journal of Gastroenterology, 93, 1380-1381. https://doi.org/10.1111/j.1572-0241.1998.427_h.x
- Tangkijvanich, P., Thong-Ngam, D. and Kullavanijaya, P. (2000) Fibrolamellar Hepatocellular Carcinoma in a Thai Man Who Presented with Hypoglycemia: Case Report and Review of the Literature. Journal of the Medical Association of Thailand, 83, 809-816.
- Teale, J.D. and Wark, G. (2004) The Effectiveness of Different Treatment Options for Non-Islet Cell Tumorhypoglycemia. Clinical Endocrinology, 60, 457-460. https://doi.org/10.1111/j.1365-2265.2004.01989.x
- Nayar, M.K., Lombard, M.G., Furlong, N.J., McNulty, S.J., Hardy, K.J. and Vora, J. (2006) Diagnosis and Management of Non-islet Cell Tumorhypoglycemia: Case Series and Review of the Literature. Endocrinologist, 16, 227-230. https://doi.org/10.1097/01.ten.0000226008.02412.0b
- Forde, J.J., Ewelukwa, O., Brar, T. and Cabrera, R. (2017) Intractable Fasting Hypoglycemia as a Manifestation of Hepatocellular Carcinoma. Case Reports in Hepatology, 2017, Article ID: 7465025. https://doi.org/10.1155/2017/7465025
- Fukuda, I., Hizuka, N., Ishikawa, Y., Yasumoto, K., Murakami, Y., Sata, A., Morita, J., Kurimoto, M., Okubo, Y. and Takano, K. (2006) Clinical Features of Insulin-Like Growth Factor-II Producing Non-Islet-Cell Tumor Hypoglycemia. Growth Hormone & IGF Research, 16, 211-216. https://doi.org/10.1016/j.ghir.2006.05.003
- Nikeghbalian, S., Bananzadeh, A. and Yarmohammadi, H. (2006) Hypoglycemia, the First Presenting Sign of Hepatocellularcarcinoma. Saudi Medical Journal, 27, 387-388.
- Yeung, R.T. (1997) Hypoglycemia in Hepatocellularcarcinoma: A Review. Hong Kong Medical Journal, 3, 297-301.
- Tang, A., Hallouch, O., Chernyak, V., Kamaya, A. and Sirlin, C.B. (2018) Epidemiology of Hepatocellular Carcinoma: Target Population Forsurveillance and Diagnosis. Abdominal Radiology, 43, 13-25. https://doi.org/10.1007/s00261-017-1209-1